← All stocks

Olema Pharmaceuticals, Inc.

OLMA No buying or selling

CIK 0001750284 #2588 in the set updated 20 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

$0.00

$0.00 against sales at will

By person

12 insiders · 0 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Bain Capital Life Sciences Investors, LLC entity

10% owner

—

4,300,000

$50.37M

−42.7%

Graham G. Walmsley

Director

—

1,408,875

$16.50M

−49.9%

Harmon Cyrus

Director

—

819,798

$9.60M

−6.1%

Myles David C.

CH. DISCOV. & NON-CLIN DEV OFF

—

687,607

$8.05M

−6.4%

BVF PARTNERS L P/IL entity

Director

—

347,970

$4.08M

−91.6%

Bohen Sean

PRESIDENT AND CEO

—

237,650

$2.78M

+57.5%

Kovacs Shane William Charles

CH. OPERATING & FINANCIAL OFF.

—

139,727

$1.64M

−71.2%

Austin Sasha Lu

VP of Finance and Controller

—

16,188

$189.63K

+260.7%

Zojwalla Naseem

CHIEF MEDICAL OFFICER

—

4,488

$52.57K

−95.3%

CLARK IAN T

Director

—

$0.00

—

RAPPAPORT ANDREW

Director

—

$0.00

—

Mitchell Shawnte

CHIEF LEGAL OFFICER

—

$0.00

—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 1

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 0

History held since 19 Nov 2020